The Application of Ursodeoxycholic Acid for the Prevention of SARS-CoV-2 Infection (COVID-19)

NCT05659654 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

95

Enrollment

OTHER

Sponsor class

Conditions

COVID-19

Interventions

DRUG: Ursodeoxycholic acid

Sponsor

Institute of Hematology & Blood Diseases Hospital, China